Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Apr 1;339(Pt 1):95–101.

Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione S-transferases.

P D McDonagh 1, D J Judah 1, J D Hayes 1, L Y Lian 1, G E Neal 1, C R Wolf 1, G C Roberts 1
PMCID: PMC1220132  PMID: 10085232

Abstract

We have used homology modelling, based on the crystal structure of the human glutathione S-transferase (GST) A1-1, to obtain the three-dimensional structures of rat GSTA3 and rat GSTA5 subunits bound to S-aflatoxinyl-glutathione. The resulting models highlight two residues, at positions 208 and 108, that could be important for determining, either directly or indirectly, substrate specificity for aflatoxin-exo-8,9-epoxide among the Alpha-class GSTs. Residues at these positions were mutated in human GSTA1-1 (Met-208, Leu-108), rat GSTA3-3 (Glu-208, His-108) and rat GSTA5-5 (Asp-208, Tyr-108): in the active rat GSTA5-5 to those in the inactive GSTA1-1; and in the inactive human GSTA1-1 and rat GSTA3-3 to those in the active rat GSTA5-5. These studies show clearly that, in all three GSTs, an aspartate residue at position 208 is a prerequisite for high activity in aflatoxin-exo-8,9-epoxide conjugation, although this alone is not sufficient; other residues in the vicinity, particularly residues 103-112, are important, perhaps for the optimal orientation of the aflatoxin-exo-8,9-epoxide in the active site for catalysis to occur.

Full Text

The Full Text of this article is available as a PDF (167.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barycki J. J., Colman R. F. Identification of the nonsubstrate steroid binding site of rat liver glutathione S-transferase, isozyme 1-1, by the steroid affinity label, 3beta-(iodoacetoxy)dehydroisoandrosterone. Arch Biochem Biophys. 1997 Sep 1;345(1):16–31. doi: 10.1006/abbi.1997.0244. [DOI] [PubMed] [Google Scholar]
  2. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  3. Buetler T. M., Eaton D. L. Complementary DNA cloning, messenger RNA expression, and induction of alpha-class glutathione S-transferases in mouse tissues. Cancer Res. 1992 Jan 15;52(2):314–318. [PubMed] [Google Scholar]
  4. Cabral J. R., Neal G. E. The inhibitory effects of ethoxyquin on the carcinogenic action of aflatoxin B1 in rats. Cancer Lett. 1983 Jun;19(2):125–132. doi: 10.1016/0304-3835(83)90146-5. [DOI] [PubMed] [Google Scholar]
  5. Cameron A. D., Sinning I., L'Hermite G., Olin B., Board P. G., Mannervik B., Jones T. A. Structural analysis of human alpha-class glutathione transferase A1-1 in the apo-form and in complexes with ethacrynic acid and its glutathione conjugate. Structure. 1995 Jul 15;3(7):717–727. doi: 10.1016/s0969-2126(01)00206-4. [DOI] [PubMed] [Google Scholar]
  6. Forrester L. M., Neal G. E., Judah D. J., Glancey M. J., Wolf C. R. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8306–8310. doi: 10.1073/pnas.87.21.8306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gopalan-Kriczky P., Jensen D. E., Lotlikar D. Conjugation of microsome generated and synthetic aflatoxin B1-8,9 epoxide and styrene oxide to glutathione by purified glutathione S-transferases from hamster and mouse livers. Cancer Lett. 1994 Oct 28;86(1):83–90. doi: 10.1016/0304-3835(94)90183-x. [DOI] [PubMed] [Google Scholar]
  8. Hayes J. D., Judah D. J., McLellan L. I., Kerr L. A., Peacock S. D., Neal G. E. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem J. 1991 Oct 15;279(Pt 2):385–398. doi: 10.1042/bj2790385. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hayes J. D., Judah D. J., McLellan L. I., Neal G. E. Contribution of the glutathione S-transferases to the mechanisms of resistance to aflatoxin B1. Pharmacol Ther. 1991;50(3):443–472. doi: 10.1016/0163-7258(91)90053-o. [DOI] [PubMed] [Google Scholar]
  10. Hayes J. D., Judah D. J., Neal G. E., Nguyen T. Molecular cloning and heterologous expression of a cDNA encoding a mouse glutathione S-transferase Yc subunit possessing high catalytic activity for aflatoxin B1-8,9-epoxide. Biochem J. 1992 Jul 1;285(Pt 1):173–180. doi: 10.1042/bj2850173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hayes J. D., Nguyen T., Judah D. J., Petersson D. G., Neal G. E. Cloning of cDNAs from fetal rat liver encoding glutathione S-transferase Yc polypeptides. The Yc2 subunit is expressed in adult rat liver resistant to the hepatocarcinogen aflatoxin B1. J Biol Chem. 1994 Aug 12;269(32):20707–20717. [PubMed] [Google Scholar]
  12. Hayes J. D., Pulford D. J. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30(6):445–600. doi: 10.3109/10409239509083491. [DOI] [PubMed] [Google Scholar]
  13. Hsu I. C., Metcalf R. A., Sun T., Welsh J. A., Wang N. J., Harris C. C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature. 1991 Apr 4;350(6317):427–428. doi: 10.1038/350427a0. [DOI] [PubMed] [Google Scholar]
  14. Johnson W. W., Ueng Y. F., Widersten M., Mannervik B., Hayes J. D., Sherratt P. J., Ketterer B., Guengerich F. P. Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: estimation of kinetic parameters. Biochemistry. 1997 Mar 18;36(11):3056–3060. doi: 10.1021/bi962537o. [DOI] [PubMed] [Google Scholar]
  15. Judah D. J., Hayes J. D., Yang J. C., Lian L. Y., Roberts G. C., Farmer P. B., Lamb J. H., Neal G. E. A novel aldehyde reductase with activity towards a metabolite of aflatoxin B1 is expressed in rat liver during carcinogenesis and following the administration of an anti-oxidant. Biochem J. 1993 May 15;292(Pt 1):13–18. doi: 10.1042/bj2920013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Judah D. J., Legg R. F., Neal G. E. Development of resistance to cytotoxicity during aflatoxin carcinogenesis. Nature. 1977 Jan 27;265(5592):343–345. doi: 10.1038/265343b0. [DOI] [PubMed] [Google Scholar]
  17. Kensler T. W., Egner P. A., Davidson N. E., Roebuck B. D., Pikul A., Groopman J. D. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases. Cancer Res. 1986 Aug;46(8):3924–3931. [PubMed] [Google Scholar]
  18. Kirby G. M., Chemin I., Montesano R., Chisari F. V., Lang M. A., Wild C. P. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol Carcinog. 1994 Oct;11(2):74–80. doi: 10.1002/mc.2940110204. [DOI] [PubMed] [Google Scholar]
  19. Kunkel T. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488–492. doi: 10.1073/pnas.82.2.488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Laskowski R. A., Rullmannn J. A., MacArthur M. W., Kaptein R., Thornton J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR. 1996 Dec;8(4):477–486. doi: 10.1007/BF00228148. [DOI] [PubMed] [Google Scholar]
  21. Lin J. K., Miller J. A., Miller E. C. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo. Cancer Res. 1977 Dec;37(12):4430–4438. [PubMed] [Google Scholar]
  22. McHugh T. E., Atkins W. M., Racha J. K., Kunze K. L., Eaton D. L. Binding of the aflatoxin-glutathione conjugate to mouse glutathione S-transferase A3-3 is saturated at only one ligand per dimer. J Biol Chem. 1996 Nov 1;271(44):27470–27474. doi: 10.1074/jbc.271.44.27470. [DOI] [PubMed] [Google Scholar]
  23. McLellan L. I., Judah D. J., Neal G. E., Hayes J. D. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors. Biochem J. 1994 May 15;300(Pt 1):117–124. doi: 10.1042/bj3000117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. McMahon G., Davis E. F., Huber L. J., Kim Y., Wogan G. N. Characterization of c-Ki-ras and N-ras oncogenes in aflatoxin B1-induced rat liver tumors. Proc Natl Acad Sci U S A. 1990 Feb;87(3):1104–1108. doi: 10.1073/pnas.87.3.1104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. McMahon G., Davis E., Wogan G. N. Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors. Proc Natl Acad Sci U S A. 1987 Jul;84(14):4974–4978. doi: 10.1073/pnas.84.14.4974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Monroe D. H., Eaton D. L. Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and mouse. Toxicol Appl Pharmacol. 1987 Sep 30;90(3):401–409. doi: 10.1016/0041-008x(87)90132-3. [DOI] [PubMed] [Google Scholar]
  27. Raney K. D., Coles B., Guengerich F. P., Harris T. M. The endo-8,9-epoxide of aflatoxin B1: a new metabolite. Chem Res Toxicol. 1992 May-Jun;5(3):333–335. doi: 10.1021/tx00027a002. [DOI] [PubMed] [Google Scholar]
  28. Raney K. D., Meyer D. J., Ketterer B., Harris T. M., Guengerich F. P. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases. Chem Res Toxicol. 1992 Jul-Aug;5(4):470–478. doi: 10.1021/tx00028a004. [DOI] [PubMed] [Google Scholar]
  29. Robens J. F., Richard J. L. Aflatoxins in animal and human health. Rev Environ Contam Toxicol. 1992;127:69–94. doi: 10.1007/978-1-4613-9751-9_3. [DOI] [PubMed] [Google Scholar]
  30. Ross R. K., Yuan J. M., Yu M. C., Wogan G. N., Qian G. S., Tu J. T., Groopman J. D., Gao Y. T., Henderson B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 1992 Apr 18;339(8799):943–946. doi: 10.1016/0140-6736(92)91528-g. [DOI] [PubMed] [Google Scholar]
  31. Sabbioni G., Skipper P. L., Büchi G., Tannenbaum S. R. Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis. 1987 Jun;8(6):819–824. doi: 10.1093/carcin/8.6.819. [DOI] [PubMed] [Google Scholar]
  32. Sali A., Blundell T. L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993 Dec 5;234(3):779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
  33. Simula T. P., Glancey M. J., Wolf C. R. Human glutathione S-transferase-expressing Salmonella typhimurium tester strains to study the activation/detoxification of mutagenic compounds: studies with halogenated compounds, aromatic amines and aflatoxin B1. Carcinogenesis. 1993 Jul;14(7):1371–1376. doi: 10.1093/carcin/14.7.1371. [DOI] [PubMed] [Google Scholar]
  34. Sinha S., Webber C., Marshall C. J., Knowles M. A., Proctor A., Barrass N. C., Neal G. E. Activation of ras oncogene in aflatoxin-induced rat liver carcinogenesis. Proc Natl Acad Sci U S A. 1988 Jun;85(11):3673–3677. doi: 10.1073/pnas.85.11.3673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Sinning I., Kleywegt G. J., Cowan S. W., Reinemer P., Dirr H. W., Huber R., Gilliland G. L., Armstrong R. N., Ji X., Board P. G. Structure determination and refinement of human alpha class glutathione transferase A1-1, and a comparison with the Mu and Pi class enzymes. J Mol Biol. 1993 Jul 5;232(1):192–212. doi: 10.1006/jmbi.1993.1376. [DOI] [PubMed] [Google Scholar]
  36. Studier F. W., Moffatt B. A. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes. J Mol Biol. 1986 May 5;189(1):113–130. doi: 10.1016/0022-2836(86)90385-2. [DOI] [PubMed] [Google Scholar]
  37. Swenson D. H., Lin J. K., Miller E. C., Miller J. A. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo. Cancer Res. 1977 Jan;37(1):172–181. [PubMed] [Google Scholar]
  38. Telakowski-Hopkins C. A., Rodkey J. A., Bennett C. D., Lu A. Y., Pickett C. B. Rat liver glutathione S-transferases. Construction of a cDNA clone complementary to a Yc mRNA and prediction of the complete amino acid sequence of a Yc subunit. J Biol Chem. 1985 May 10;260(9):5820–5825. [PubMed] [Google Scholar]
  39. Van Ness K. P., Buetler T. M., Eaton D. L. Enzymatic characteristics of chimeric mYc/rYc1 glutathione S-transferases. Cancer Res. 1994 Sep 1;54(17):4573–4575. [PubMed] [Google Scholar]
  40. de Groot M. J., Vermeulen N. P., Mullenders D. L., Donné-Op den Kelder G. M. A homology model for rat mu class glutathione S-transferase 4-4. Chem Res Toxicol. 1996 Jan-Feb;9(1):28–40. doi: 10.1021/tx950082i. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES